Dynamic Voltage Mapping to guide ablation for ventricular tachycardia
Tests a mapping technique to find heart scar during ablation for ventricular tachycardia.
Key facts
- Who runs it
- Liverpool Heart and Chest Hospital NHS Foundation Trust
- Where
- Liverpool, United KingdomSee the site
- Trial code
- Registry title
- Dynamic Voltage Mapping to Personalise the Ventricular Tachycardia Substrate
- Status
- Recruiting
- People taking part
- 40 people, planned
- Started
- 3 Aug 2026
- Expected to end
- 1 Aug 2029
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Dynamic Voltage Mapping
- Standard of Care Ablation
- Record updated
- 8 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with ventricular tachycardia (VT), a dangerous fast heart rhythm, who are scheduled for VT ablation. Ablation uses thin tubes to destroy the faulty heart tissue.
- Age
- 18 to 85 years
- Sex
- Male or female
- Disease stage
- Sustained VT episodes or ICD therapies, with ischaemic or non-ischaemic cardiomyopathy (heart muscle disease).
- Earlier treatment
- People must already have an ICD (implanted heart defibrillator) in place.
Main reasons for not taking part
- NYHA Class IV (end stage heart failure)
- Metastatic cancer (cancer that has spread)
- End stage kidney disease
- Pregnant or breast feeding
- Severe frailty
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Scheduled for clinically indicated VT ablation (due to sustained VT episodes or ICD therapies)
- Willing and able to give informed consent for participation in the trial
- Male or female aged between 18-85
- Ischaemic and non-ischaemic cardiomyopathy
- ICD insitu
Who cannot take part
- NYHA Class IV (end stage heart failure)
- Metastatic cancer
- End stage renal disease
- Unable or unwilling to consent
- Pregnant or breast feeding
- Severe frailty
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 85 years old?
Where in United Kingdom
- Liverpool Heart and Chest Hospital NHS Foundation TrustLiverpool, United KingdomContact: Vishal Luther, MRCP PhD ECES ECDSTaking people
About the trial
What the trial wants to find out
Ventricular tachycardia (VT) is a life-threatening heart rhythm disorder and one of the commonest causes of heart-related sudden death. It often affects people who have had a heart attack or other structural heart damage. VT occurs when abnormal electrical circuits develop within and around scar tissue in the heart.
Read full original descriptionShow less
People at risk are usually offered an implantable cardiac defibrillator (ICD), a device that can detect VT and deliver a lifesaving shock. While effective, these shocks can be sudden, painful and distressing. Medications such as amiodarone can also help, but they are often unsuitable for long-term use due to their potential side effects on the liver, lungs and thyroid gland.
An alternative is catheter ablation. Thin tubes (catheters) are threaded from a blood vessel in the groin to the heart, allowing the cardiologist to identify scar tissue and abnormal electrical circuits, which can be destroyed using heat, freezing or electrical energy.
Although ablation can help many patients, VT can return in up to one in three people after the procedure. This is because it can be difficult to precisely identify the scar and surrounding tissue that sustain the abnormal circuits, making it challenging to know exactly where to apply ablation treatment.
Dynamic Voltage Mapping, is a technique which the investigators believe can more accurately identify scar and the critical bordering tissue during ablation. Initial data collected suggests that the approach accurately predicts the VT circuit and helps guide ablation.
In this study, the investigators wish to recruit 40 participants undergoing VT ablation to determine how effective Dynamic Voltage Mapping is in real-world procedures.
The 2 groups in the trial
- Dynamic Voltage Mapping Guided AblationTreatment being tested
Patients assigned to this group will have Dynamic Voltage Maps available for the operator to view during the procedure to help guide ablation.
Treatment: Dynamic Voltage Mapping
- Standard of Care AblationExisting treatment, for comparison
Patients assigned to this group will receive standard of care ablation, and operators will be blinded to Dynamic Voltage Maps created during the procedure.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Dynamic Voltage Mapping to Personalise the Ventricular Tachycardia Substrate
- Plain-language title
- Dynamic Voltage Mapping to guide ablation for ventricular tachycardiaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT07573579, who can take part
- Record updated
- 8 October 2026